sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Side
Planned sales
Role
KROS
Updated 10/6/2026, 8:11 AM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| KROS Keros Therapeutics, Inc. | Sale | $12,595 | Tanini Annita Corp. Controller & VP, Finance | 1,224 sh | at $10.29 | Filed Aug 20, 4:10 PM ET | Filing | |
| KROS Keros Therapeutics, Inc. | Sale | $36,715 | Lerner Lorena Raquel Chief Scientific Officer | 3,568 sh | at $10.29 | Filed Aug 20, 4:10 PM ET | Filing | |
| KROS Keros Therapeutics, Inc. | Sale | $46,151 | Cho Esther Chief Legal Officer | 4,485 sh | at $10.29 | Filed Aug 20, 4:10 PM ET | Filing | |
| KROS Keros Therapeutics, Inc. | Sale | $5,675 | Newton Charles W. Director | 551 sh | at $10.30 | Filed Aug 20, 4:10 PM ET | Filing | |
| KROS Keros Therapeutics, Inc. | Buy | $10,270 | BIENAIME JEAN JACQUES Director | 1,000 sh | at $10.27 | Filed Aug 19, 4:10 PM ET | Filing | |
| KROS Keros Therapeutics, Inc. | Buy | $10,610 | BIENAIME JEAN JACQUES Director | 1,000 sh | at $10.61 | Filed Jul 17, 4:10 PM ET | Filing |